<unk>  is used to treat adults with moderate to severe rheumatoid arthritis (RA) as a second-line agent, and as a first-line agent for people whose RA is severe and rapidly progressing. It also used to treat psoriatic arthritis and juvenile idiopathic arthritis.
Abatacept
Belatacept
Theralizumab
Atezolizumab
Risankizumab
Adalimumab
Ocrelizumab
Etaracizumab